STUDIES & SURVEYS: Say Goodbye To Drug Reps -- And Gain An Extra $12,000

Article Overview

This article summarizes survey findings and commentary about physician time spent meeting with drug company representatives, how that time may affect practice scheduling, and the financial opportunity cost discussed in the context of outpatient office visits. It is aimed at physicians, practice managers, and coding/billing professionals who track workflow, revenue impact, and general utilization trends tied to ambulatory services and industry interaction. The piece also references broader study findings about drug samples and catered meals, but does not present detailed coding guidance.